Centrus Energy: Key Enabler Of U.S. Advanced Nuclear Technology
Centrus Energy is benefiting from its critical point in the U.S. nuclear fuel cycle, enabling the next-generation reactor development. LEU could benefit substantially from its centrifuge cascade technology due to the growing need for nuclear power. The SWU potential could reach up to 70 million once SMRs and advanced reactors start deploying, implying the company could grow at a 20% rate going forward.
Centrus Energy: The Nuclear Fuel Breakout The Market Isn't Pricing Yet
Centrus strengthened its position with $1.6B cash, a $3.9B backlog and rising structural demand for US enrichment despite a 30% stock pullback. Q3 showed 30% YoY revenue growth and normal margin volatility driven by contract mix, but YTD profit climbed to $60MM vs $19.5MM in 2024. Industrial preparation accelerated ahead of DOE awards, including staffing, manufacturing work and increased interest from utilities, international partners and hyperscalers.
Should You Buy Centrus Energy While It's Below $270?
Nuclear power is gaining renewed interest due to increasing electricity demand from advances in AI. Centrus Energy plays a critical role in the nuclear supply chain, providing low-enriched uranium and advanced uranium enrichment services.
LEU Stock Falls 11% Post Q3 Earnings Miss: Time to Buy, Hold or Sell?
Centrus Energy slips 11% after Q3 miss, but its 333.9% YTD surge and HALEU expansion plans keep its long-term story strong.
Centrus Energy Corp. (LEU) Misses Q3 Earnings and Revenue Estimates
Centrus Energy Corp. (LEU) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.2 per share. This compares to a loss of $0.3 per share a year ago.
Should You Buy, Sell or Hold LEU Stock Before Q3 Earnings Release?
Centrus Energy gears up for Q3 results with revenues up 32% and a profit rebound expected, though an earnings beat remains unclear.
LEU vs. CCJ: Which Stock Has More Power for Growth Right Now?
As nuclear demand surges worldwide, Centrus Energy and Cameco stand out, but Centrus' HALEU edge makes it the brighter investment bet.
Centrus Energy's Revenues Slip 2% in 1H25: Recovery Ahead?
LEU's 1H25 revenues dip 2% as weak uranium sales offset solid gains in its Technical segment.
Centrus Energy: 5 Letters You Need To Know For The Next Decade - HALEU
Centrus Energy is the only U.S. company licensed to produce next-gen nuclear fuel (HALEU), positioning it for significant future growth. LEU's unique regulatory position and anticipated HALEU demand could drive dramatic revenue and profit expansion over the next decade. Despite strong long-term prospects, LEU trades at a steep valuation (80x earnings), with meaningful growth not expected until the 2030s.
Strength Seen in Centrus Energy (LEU): Can Its 12.1% Jump Turn into More Strength?
Centrus Energy (LEU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
LEU vs. UEC: Which Uranium Stock is the Smarter Bet Right Now?
Centrus Energy stands out with exclusive HALEU production rights, a strong backlog and better valuation compared with Uranium Energy.
LEU vs. UUUU: Which Uranium Stock is the Smarter Bet Right Now?
Centrus Energy and Energy Fuels face diverging growth paths as nuclear demand rises, with LEU gaining an edge on estimates and valuation.
